LEG
36
5
SO
48
-2
TAP
61
-3
GPC
37
-3
CMS
54
-3
URI
45
-4
DLTR
51
-3
WYNN
32
2
EQT
47
8
MAR
65
2
XEL
53
-2
DD
55
2
GOOG
87
6
FLR
52
4
PRU
47
-4
ADT
37
4
PEP
41
-6
XOM
37
-2
PWR
67
5
TDC
86
2
LEG
36
5
SO
48
-2
TAP
61
-3
GPC
37
-3
CMS
54
-3
URI
45
-4
DLTR
51
-3
WYNN
32
2
EQT
47
8
MAR
65
2
XEL
53
-2
DD
55
2
GOOG
87
6
FLR
52
4
PRU
47
-4
ADT
37
4
PEP
41
-6
XOM
37
-2
PWR
67
5
TDC
86
2
Financhill
Back

Invesco S&P Intl Dev Div ArstcrtsESG Vs. Aligos Therapeutics Industry Stock Comparison

Sell
38

IIAE.TO
Invesco S&P Intl Dev Div ArstcrtsESG

Last Price:
25.23
Seasonality Move:
3.72%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
33.82
Seasonality Move:
10.65%
Sell
38
Invesco S&P Intl Dev Div ArstcrtsESG (IIAE.TO) is a Sell

Is Invesco S&P Intl Dev Div ArstcrtsESG a Buy, Sell or Hold?

  • The current Invesco S&P Intl Dev Div ArstcrtsESG [IIAE.TO] share price is $25.23. The Score for IIAE.TO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • IIAE.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IIAE.TO Stock Price Chart

What is Invesco S&P Intl Dev Div ArstcrtsESG's stock price today?

  • The Invesco S&P Intl Dev Div ArstcrtsESG share price today is $25.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IIAE.TO is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

IIAE.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 69.58 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.51 - 25.17) Buy
Bollinger Bands (100): (24.49 - 25.31) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

IIAE.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.15 Buy
20-day SMA: 24.81 Buy
50-day SMA: 25.03 Buy
200-day SMA: 23.81 Buy
8-day EMA: 25.12 Buy
20-day EMA: 24.98 Buy
50-day EMA: 24.95 Buy
200-day EMA: 23.92 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

Invesco S&P Intl Dev Div ArstcrtsESG Earnings Growth & IIAE.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Invesco S&P Intl Dev Div ArstcrtsESG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):